ARCHIVES

Second-Generation CML Drugs Show Promise For Frontline

This article is from The Cancer Letter archive.

Vol. 31 No. 12 | December 26, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief : Three Named To Leadership Posts At St. Jude; Mitchell Weiss Appointed Chair of Hematology

July 11, 2014

ACCC To Take In State Chapters, Forms Trials Group

April 6, 1990

NCI-Approved Clinical Trials Listed For April 2001

May 25, 2001

Drug Development Effort Criticized

April 18, 1975

Group Urges U.S., USSR Exchange In Surgical Oncology

January 6, 1989

Cancer Webmasters Seek to Develop Tools for Greater Use of NCI Cancer Information

May 5, 2000